| GC34390-10mg |
|
— |
|
0 |
C65H119N23O19 |
|
|
|
| GC34390-5mg |
|
— |
|
0 |
C65H119N23O19 |
|
|
|
| GC34390-1mg |
|
— |
|
0 |
C65H119N23O19 |
|
|
|
| GC34389-10mg |
|
— |
|
0 |
C128H202N42O43S |
|
|
|
| GC34389-5mg |
|
— |
|
0 |
C128H202N42O43S |
|
|
|
| GC34389-1mg |
|
— |
|
0 |
C128H202N42O43S |
|
|
|
| GC34388-10mg |
|
— |
|
0 |
C74H115N23O23S2.C2HF3O2 |
|
|
|
| GC34388-5mg |
|
— |
|
0 |
C74H115N23O23S2.C2HF3O2 |
|
|
|
| GC34388-1mg |
|
— |
|
0 |
C74H115N23O23S2.C2HF3O2 |
|
|
|
| GC34387-10mg |
|
— |
|
0 |
C40H64F3N9O11 |
|
|
|
| GC34387-5mg |
|
— |
|
0 |
C40H64F3N9O11 |
|
|
|
| GC34387-1mg |
|
— |
|
0 |
C40H64F3N9O11 |
|
|
|
| GC34387-10mM(1mLinDMSO) |
|
— |
|
0 |
C40H64F3N9O11 |
|
|
|
| GC34386-5mg |
|
— |
ALX 40-4C Trifluoroacetate
|
0 |
C58H114F3N37O12 |
|
|
|
| GC34386-1mg |
|
— |
ALX 40-4C Trifluoroacetate
|
0 |
C58H114F3N37O12 |
|
|
|
| GC34385-100mg |
|
— |
Protein kinase inhibitors 1 hydrochloride ((E)-5-((2-Oxo-6’-(piperazin-1-yl)-1,2-dihydro-[3,3’-bipyridin]-5-yl)methylene)thiazolidine-2,4-dione hydrochloride)
|
0 |
C18H18ClN5O3S |
|
|
|
| GC34385-50mg |
|
— |
Protein kinase inhibitors 1 hydrochloride ((E)-5-((2-Oxo-6’-(piperazin-1-yl)-1,2-dihydro-[3,3’-bipyridin]-5-yl)methylene)thiazolidine-2,4-dione hydrochloride)
|
0 |
C18H18ClN5O3S |
|
|
|
| GC34385-25mg |
|
— |
Protein kinase inhibitors 1 hydrochloride ((E)-5-((2-Oxo-6’-(piperazin-1-yl)-1,2-dihydro-[3,3’-bipyridin]-5-yl)methylene)thiazolidine-2,4-dione hydrochloride)
|
0 |
C18H18ClN5O3S |
|
|
|
| GC34385-10mg |
|
— |
Protein kinase inhibitors 1 hydrochloride ((E)-5-((2-Oxo-6’-(piperazin-1-yl)-1,2-dihydro-[3,3’-bipyridin]-5-yl)methylene)thiazolidine-2,4-dione hydrochloride)
|
0 |
C18H18ClN5O3S |
|
|
|
| GC34385-5mg |
|
— |
Protein kinase inhibitors 1 hydrochloride ((E)-5-((2-Oxo-6’-(piperazin-1-yl)-1,2-dihydro-[3,3’-bipyridin]-5-yl)methylene)thiazolidine-2,4-dione hydrochloride)
|
0 |
C18H18ClN5O3S |
|
|
|
